Market Cap (In CNY)
5.87 Billion
Revenue (In CNY)
691.54 Million
Net Income (In CNY)
32.69 Million
Avg. Volume
3.84 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 9.82-17.43
- PE
- -
- EPS
- -
- Beta Value
- -0.231
- ISIN
- CNE100003308
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Xiaoying Liu
- Employee Count
- -
- Website
- https://www.pharscin.com
- Ipo Date
- 2017-10-20
- Details
- Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, hard capsules, soft capsules, powder injections, freeze-dried powder injections, small volume injections, and API synthesis. It provides its products in the areas of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.
More Stocks
-
MUX
-
IXC
-
1289
-
FUND
-
MANKINDMankind Pharma Limited
MANKIND
-
RCC
-
KHNGF
-
IMCCIM Cannabis Corp.
IMCC